{"id":4037,"date":"2026-08-20T13:38:00","date_gmt":"2026-08-20T13:38:00","guid":{"rendered":"https:\/\/futurenews24.com\/index.php\/2026\/08\/20\/utm_campaignrss-36\/"},"modified":"2026-08-21T07:59:11","modified_gmt":"2026-08-21T07:59:11","slug":"utm_campaignrss-36","status":"publish","type":"post","link":"https:\/\/futurenews24.com\/index.php\/2026\/08\/20\/utm_campaignrss-36\/","title":{"rendered":"Ultragenyx, Regeneron, Merck, Moderna: Readout Publication"},"content":{"rendered":"<p><br \/>\n<\/p>\n<div>\n<p class=\"wp-block-paragraph\">Need to keep on high of the science and politics driving biotech at present?\u00a0Enroll\u00a0to get our biotech e-newsletter in your inbox.<\/p>\n<p class=\"wp-block-paragraph\">Right this moment, we discuss extra about Merck and Moderna\u2019s doubtlessly field-changing most cancers vaccine, see a pair FDA approvals, and study extra in regards to the new FDA commissioner\u00a0nominee. Plus, mind organoids have stayed alive \u2014 and proceed to mature \u2014 in a Harvard lab for 5 years.<\/p>\n<p class=\"wp-block-paragraph\">I ponder, really,\u00a0in regards to the\u00a0poor little mind organoids in Megan\u2019s story. Simply pulsing of their Petri dishes, considering ethical relativity or migraines. It\u2019s all very Robin Prepare dinner.<\/p>\n<div class=\"restricted-content-breaker article\" aria-labelledby=\"restricted-story-heading\" aria-describedby=\"restricted-story-description\" checked=\"false\">\n<div class=\"restricted-content-breaker-bar\">\n<p class=\"restricted-text\">STAT+ Unique Story<\/p>\n<p class=\"restricted-login\">Have already got an account? Log in<\/p>\n<\/p><\/div>\n<p>\t\t\t<img decoding=\"async\" class=\"restricted-content-breaker-bg\" src=\"https:\/\/www.statnews.com\/wp-content\/themes\/stat\/images\/stat-plus-breaker-bg.png\" alt=\"STAT+\"\/><\/p>\n<div class=\"restricted-content-breaker-wrapper\">\n\t\t\t\t<span class=\"stat-paywall-archive\"><\/p>\n<p>\t\t\t\t\t\t<img decoding=\"async\" class=\"stat-plus-logo\" src=\"https:\/\/www.statnews.com\/wp-content\/themes\/stat\/images\/stat-plus-logo-white.svg\" alt=\"STAT+\"\/><\/p>\n<p>\t\t\t\t<\/span><\/p>\n<h2 id=\"restricted-story-heading\">This text is unique to STAT+ subscribers<\/h2>\n<h3 id=\"restricted-story-description\">Unlock this text \u2014 plus in-depth evaluation, newsletters, premium occasions, and information alerts.<\/h3>\n<p class=\"restricted-content-breaker-wrapper-cta mobile\">Have already got an account? Log in<\/p>\n<div class=\"restricted-content-breaker-cards\">\n<div class=\"slider-container\" aria-label=\"Subscription plan toggle\">\n\t\t\t\t\t\tParticular person plans<\/p>\n<p>\t\t\t\t\t\tGroup plans\n\t\t\t\t\t<\/p><\/div><\/div>\n<p>\t\t\t\tView All Plans\n\t\t\t<\/p><\/div><\/div>\n<div class=\"restricted-message-breaker\">\n<div class=\"restricted-content-wrapper\">\n<div class=\"restricted-content-message\">\n<p class=\"restricted-content-text\">\n\t\t\t\t\t\tTo learn the remainder of this story subscribe to STAT+.\t\t\t\t\t<\/p>\n<p>\t\t\t\t\tSubscribe\n\t\t\t\t\t\t\t\t\t<\/p><\/div><\/div><\/div><\/div>\n<p><br \/>\n<br \/><a href=\"https:\/\/www.statnews.com\/2026\/08\/20\/biotech-news-fda-approves-utlragenyx-gene-therapy\/?utm_campaign=rss\">Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Need to keep on high of the science and politics driving biotech at present?\u00a0Enroll\u00a0to get our biotech e-newsletter in your inbox. Right this moment, we discuss extra about Merck and Moderna\u2019s doubtlessly field-changing most cancers vaccine, see a pair FDA approvals, and study extra in regards to the new FDA commissioner\u00a0nominee. Plus, mind organoids have [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":4039,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"fifu_image_url":"https:\/\/www.statnews.com\/wp-content\/uploads\/2024\/05\/s3___bgmp-arc_arc-feeds_generic-photos_to-arc_Wiggs-_Bedford_2-1024x576.jpg","fifu_image_alt":"","jnews-multi-image_gallery":[],"jnews_single_post":[],"jnews_primary_category":[],"jnews_override_bookmark_settings":[],"jnews_social_meta":[],"jnews_override_counter":[],"footnotes":""},"categories":[10],"tags":[1737,4320,212,263,4319,4318],"class_list":["post-4037","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-biotechnology","tag-merck","tag-moderna","tag-newsletter","tag-readout","tag-regeneron","tag-ultragenyx"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Ultragenyx, Regeneron, Merck, Moderna: Readout Publication - Future News 24<\/title>\n<meta name=\"description\" content=\"Today&#039;s biotech news includes Regeneron winning ultra-rare disease drug approval, a validating success for mRNA research, and more\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/futurenews24.com\/index.php\/2026\/08\/20\/utm_campaignrss-36\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ultragenyx, Regeneron, Merck, Moderna: Readout Publication - Future News 24\" \/>\n<meta property=\"og:description\" content=\"Today&#039;s biotech news includes Regeneron winning ultra-rare disease drug approval, a validating success for mRNA research, and more\" \/>\n<meta property=\"og:url\" content=\"https:\/\/futurenews24.com\/index.php\/2026\/08\/20\/utm_campaignrss-36\/\" \/>\n<meta property=\"og:site_name\" content=\"Future News 24\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-20T13:38:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-21T07:59:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.statnews.com\/wp-content\/uploads\/2024\/05\/s3___bgmp-arc_arc-feeds_generic-photos_to-arc_Wiggs-_Bedford_2-1024x576.jpg\" \/>\n<meta name=\"author\" content=\"Future News 24\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.statnews.com\/wp-content\/uploads\/2024\/05\/s3___bgmp-arc_arc-feeds_generic-photos_to-arc_Wiggs-_Bedford_2-1024x576.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Future News 24\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/08\\\/20\\\/utm_campaignrss-36\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/08\\\/20\\\/utm_campaignrss-36\\\/\"},\"author\":{\"name\":\"Future News 24\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#\\\/schema\\\/person\\\/cecad1bde21cfc357cf70128144d6c83\"},\"headline\":\"Ultragenyx, Regeneron, Merck, Moderna: Readout Publication\",\"datePublished\":\"2026-08-20T13:38:00+00:00\",\"dateModified\":\"2026-08-21T07:59:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/08\\\/20\\\/utm_campaignrss-36\\\/\"},\"wordCount\":169,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/08\\\/20\\\/utm_campaignrss-36\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.statnews.com\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/s3___bgmp-arc_arc-feeds_generic-photos_to-arc_Wiggs-_Bedford_2-1024x576.jpg\",\"keywords\":[\"Merck\",\"Moderna\",\"Newsletter\",\"Readout\",\"Regeneron\",\"Ultragenyx\"],\"articleSection\":[\"BioTechnology\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/08\\\/20\\\/utm_campaignrss-36\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/08\\\/20\\\/utm_campaignrss-36\\\/\",\"url\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/08\\\/20\\\/utm_campaignrss-36\\\/\",\"name\":\"Ultragenyx, Regeneron, Merck, Moderna: Readout Publication - Future News 24\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/08\\\/20\\\/utm_campaignrss-36\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/08\\\/20\\\/utm_campaignrss-36\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.statnews.com\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/s3___bgmp-arc_arc-feeds_generic-photos_to-arc_Wiggs-_Bedford_2-1024x576.jpg\",\"datePublished\":\"2026-08-20T13:38:00+00:00\",\"dateModified\":\"2026-08-21T07:59:11+00:00\",\"description\":\"Today&#039;s biotech news includes Regeneron winning ultra-rare disease drug approval, a validating success for mRNA research, and more\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/08\\\/20\\\/utm_campaignrss-36\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/08\\\/20\\\/utm_campaignrss-36\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/08\\\/20\\\/utm_campaignrss-36\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.statnews.com\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/s3___bgmp-arc_arc-feeds_generic-photos_to-arc_Wiggs-_Bedford_2-1024x576.jpg\",\"contentUrl\":\"https:\\\/\\\/www.statnews.com\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/s3___bgmp-arc_arc-feeds_generic-photos_to-arc_Wiggs-_Bedford_2-1024x576.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/08\\\/20\\\/utm_campaignrss-36\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/futurenews24.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ultragenyx, Regeneron, Merck, Moderna: Readout Publication\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#website\",\"url\":\"https:\\\/\\\/futurenews24.com\\\/\",\"name\":\"Future News 24\",\"description\":\"The Smart Hub for AI and Next-Gen Innovation\",\"publisher\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/futurenews24.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#organization\",\"name\":\"Future News 24\",\"url\":\"https:\\\/\\\/futurenews24.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/futurenews24.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/fn24-favicon.png\",\"contentUrl\":\"https:\\\/\\\/futurenews24.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/fn24-favicon.png\",\"width\":250,\"height\":250,\"caption\":\"Future News 24\"},\"image\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#\\\/schema\\\/person\\\/cecad1bde21cfc357cf70128144d6c83\",\"name\":\"Future News 24\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d57f07142d73cb5503ab2446ea7bc9ef3d0a5ba378d64a6157692311e42bf097?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d57f07142d73cb5503ab2446ea7bc9ef3d0a5ba378d64a6157692311e42bf097?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d57f07142d73cb5503ab2446ea7bc9ef3d0a5ba378d64a6157692311e42bf097?s=96&d=mm&r=g\",\"caption\":\"Future News 24\"},\"sameAs\":[\"https:\\\/\\\/futurenews24.com\"],\"url\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/author\\\/mridulpahuja20\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ultragenyx, Regeneron, Merck, Moderna: Readout Publication - Future News 24","description":"Today&#039;s biotech news includes Regeneron winning ultra-rare disease drug approval, a validating success for mRNA research, and more","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/futurenews24.com\/index.php\/2026\/08\/20\/utm_campaignrss-36\/","og_locale":"en_US","og_type":"article","og_title":"Ultragenyx, Regeneron, Merck, Moderna: Readout Publication - Future News 24","og_description":"Today&#039;s biotech news includes Regeneron winning ultra-rare disease drug approval, a validating success for mRNA research, and more","og_url":"https:\/\/futurenews24.com\/index.php\/2026\/08\/20\/utm_campaignrss-36\/","og_site_name":"Future News 24","article_published_time":"2026-08-20T13:38:00+00:00","article_modified_time":"2026-08-21T07:59:11+00:00","og_image":[{"url":"https:\/\/www.statnews.com\/wp-content\/uploads\/2024\/05\/s3___bgmp-arc_arc-feeds_generic-photos_to-arc_Wiggs-_Bedford_2-1024x576.jpg","type":"","width":"","height":""}],"author":"Future News 24","twitter_card":"summary_large_image","twitter_image":"https:\/\/www.statnews.com\/wp-content\/uploads\/2024\/05\/s3___bgmp-arc_arc-feeds_generic-photos_to-arc_Wiggs-_Bedford_2-1024x576.jpg","twitter_misc":{"Written by":"Future News 24","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/futurenews24.com\/index.php\/2026\/08\/20\/utm_campaignrss-36\/#article","isPartOf":{"@id":"https:\/\/futurenews24.com\/index.php\/2026\/08\/20\/utm_campaignrss-36\/"},"author":{"name":"Future News 24","@id":"https:\/\/futurenews24.com\/#\/schema\/person\/cecad1bde21cfc357cf70128144d6c83"},"headline":"Ultragenyx, Regeneron, Merck, Moderna: Readout Publication","datePublished":"2026-08-20T13:38:00+00:00","dateModified":"2026-08-21T07:59:11+00:00","mainEntityOfPage":{"@id":"https:\/\/futurenews24.com\/index.php\/2026\/08\/20\/utm_campaignrss-36\/"},"wordCount":169,"commentCount":0,"publisher":{"@id":"https:\/\/futurenews24.com\/#organization"},"image":{"@id":"https:\/\/futurenews24.com\/index.php\/2026\/08\/20\/utm_campaignrss-36\/#primaryimage"},"thumbnailUrl":"https:\/\/www.statnews.com\/wp-content\/uploads\/2024\/05\/s3___bgmp-arc_arc-feeds_generic-photos_to-arc_Wiggs-_Bedford_2-1024x576.jpg","keywords":["Merck","Moderna","Newsletter","Readout","Regeneron","Ultragenyx"],"articleSection":["BioTechnology"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/futurenews24.com\/index.php\/2026\/08\/20\/utm_campaignrss-36\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/futurenews24.com\/index.php\/2026\/08\/20\/utm_campaignrss-36\/","url":"https:\/\/futurenews24.com\/index.php\/2026\/08\/20\/utm_campaignrss-36\/","name":"Ultragenyx, Regeneron, Merck, Moderna: Readout Publication - Future News 24","isPartOf":{"@id":"https:\/\/futurenews24.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/futurenews24.com\/index.php\/2026\/08\/20\/utm_campaignrss-36\/#primaryimage"},"image":{"@id":"https:\/\/futurenews24.com\/index.php\/2026\/08\/20\/utm_campaignrss-36\/#primaryimage"},"thumbnailUrl":"https:\/\/www.statnews.com\/wp-content\/uploads\/2024\/05\/s3___bgmp-arc_arc-feeds_generic-photos_to-arc_Wiggs-_Bedford_2-1024x576.jpg","datePublished":"2026-08-20T13:38:00+00:00","dateModified":"2026-08-21T07:59:11+00:00","description":"Today&#039;s biotech news includes Regeneron winning ultra-rare disease drug approval, a validating success for mRNA research, and more","breadcrumb":{"@id":"https:\/\/futurenews24.com\/index.php\/2026\/08\/20\/utm_campaignrss-36\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/futurenews24.com\/index.php\/2026\/08\/20\/utm_campaignrss-36\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/futurenews24.com\/index.php\/2026\/08\/20\/utm_campaignrss-36\/#primaryimage","url":"https:\/\/www.statnews.com\/wp-content\/uploads\/2024\/05\/s3___bgmp-arc_arc-feeds_generic-photos_to-arc_Wiggs-_Bedford_2-1024x576.jpg","contentUrl":"https:\/\/www.statnews.com\/wp-content\/uploads\/2024\/05\/s3___bgmp-arc_arc-feeds_generic-photos_to-arc_Wiggs-_Bedford_2-1024x576.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/futurenews24.com\/index.php\/2026\/08\/20\/utm_campaignrss-36\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/futurenews24.com\/"},{"@type":"ListItem","position":2,"name":"Ultragenyx, Regeneron, Merck, Moderna: Readout Publication"}]},{"@type":"WebSite","@id":"https:\/\/futurenews24.com\/#website","url":"https:\/\/futurenews24.com\/","name":"Future News 24","description":"The Smart Hub for AI and Next-Gen Innovation","publisher":{"@id":"https:\/\/futurenews24.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/futurenews24.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/futurenews24.com\/#organization","name":"Future News 24","url":"https:\/\/futurenews24.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/futurenews24.com\/#\/schema\/logo\/image\/","url":"https:\/\/futurenews24.com\/wp-content\/uploads\/2026\/06\/fn24-favicon.png","contentUrl":"https:\/\/futurenews24.com\/wp-content\/uploads\/2026\/06\/fn24-favicon.png","width":250,"height":250,"caption":"Future News 24"},"image":{"@id":"https:\/\/futurenews24.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/futurenews24.com\/#\/schema\/person\/cecad1bde21cfc357cf70128144d6c83","name":"Future News 24","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/d57f07142d73cb5503ab2446ea7bc9ef3d0a5ba378d64a6157692311e42bf097?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/d57f07142d73cb5503ab2446ea7bc9ef3d0a5ba378d64a6157692311e42bf097?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d57f07142d73cb5503ab2446ea7bc9ef3d0a5ba378d64a6157692311e42bf097?s=96&d=mm&r=g","caption":"Future News 24"},"sameAs":["https:\/\/futurenews24.com"],"url":"https:\/\/futurenews24.com\/index.php\/author\/mridulpahuja20\/"}]}},"_links":{"self":[{"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/posts\/4037","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/comments?post=4037"}],"version-history":[{"count":1,"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/posts\/4037\/revisions"}],"predecessor-version":[{"id":4038,"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/posts\/4037\/revisions\/4038"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/media\/4039"}],"wp:attachment":[{"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/media?parent=4037"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/categories?post=4037"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/tags?post=4037"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}